Related Experiment Videos
[Hyperlipemias and obliterating peripheral arteriopathies]
Insights
Peripheral obliterating arteriopathy patients show high lipid alterations, with 44% affected. This highlights hyperlipidemia as a significant risk factor in peripheral vascular diseases, necessitating intervention.
Area of Science:
- Vascular Medicine
- Lipidology
- Arteriosclerosis Research
Context:
- Peripheral obliterating arteriopathy (POA) is a significant vascular condition.
- Lipid alterations are suspected contributors to arteriosclerotic disease progression.
- Understanding lipid profiles in POA patients is crucial for risk assessment.
Purpose:
- To investigate the frequency and types of lipid alterations in patients with radiologically confirmed POA.
- To compare lipid alteration prevalence in POA patients versus a healthy control group.
- To establish the role of hyperlipidemia as a modifiable risk factor in POA.
Summary:
- A study of 160 POA patients revealed lipid alterations in 44%, with Fredrikson types II, III, and IV observed at 12.5%, 7.4%, and 24% respectively.
- In female POA patients, lipid alterations occurred in 50%, with specific type distributions.
- The control group showed an 18.7% incidence of lipid alterations, significantly lower than the POA cohort.
Impact:
- The high incidence of hyperlipidemia in POA underscores its importance as an arteriosclerotic risk factor.
- Findings support the need for targeted dietetic and pharmacological interventions for POA prevention and treatment.
- This research contributes to managing vascular disease by addressing lipid metabolism abnormalities.
Abstract:
160 patients suffering from radiologically confirmed peripheral obliterating arteriopathy have been studied with respect to frequency of lipid alterations. The resulting data were compared with those observed in a group of clinically healthy subjects. In the arteriopathic series, lipid alterations were encountered in 44% of patients, with a percentage of 12.5% for Fredrikson type II, 7.4% for III and 24% for IV. In women, incidence attained 50% and type classification was 25% for the 2nd, 12.5% for the 3rd and 14.5% for the 4th. An alteration of 18.7% was encountered in the control group. The high frequency of hyperlipidaemia in peripheral vascular diseases reported in the literature and confirmed by the above data, justifies the employement of appropriate dietetic and pharmacological measures for the prevention and treatment of this arteriosclerotic disease risk factor.